Disclosed herein are compounds of the formula: A--N(R.sup.1)C(O)CH.sub.2 CHR.sup.2 C(O)--B wherein A is R.sup.3 R.sup.4 NC(O)CH.sub.2 wherein, for example, R.sup.3 is hydrogen or alkyl and R.sup.4 is hydrogen, alkyl or a substituted alkyl such as 2-(2-pyridinyl)ethyl, or R.sup.3 and R.sup.4 together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino, morpholino or thiomorpholino; R.sup.1 is, for example, benzyl, alkyl or a substituted alkyl such as cyclohexylmethyl; R.sup.2 is, for example, alkyl, cycloalkylmethyl, 1H-imidazol-4-ylmethyl, 4-thiazolylmethyl or (2-amino-4-thiazolyl)methyl; and B is a renin substrate transition state analog, for example, [1(S)-(cyclohexylmethyl)-2(R),3(S)-dihydroxy-5-methylhexyl]amino. The compounds inhibit renin activity and are indicated for the treatment of hypertension and congestive heart failure.
本文揭示了以下公式的化合物:A-N(R.sup.1)C(O)CH.sub.2 CHR.sup.2 C(O)-B,其中A为R.sup.3 R.sup.4 NC(O)CH.sub.2,例如,R.sup.3为氢或烷基,R.sup.4为氢,烷基或取代烷基,如2-(2-
吡啶基)乙基,或者R.sup.3和R.sup.4与它们连接的氮原子一起形成
吡咯烷基,
哌啶基,吗啶基或
硫代吗啶基;R.sup.1为例如苄基,烷基或取代烷基,如环己基甲基;R.sup.2为例如烷基,环烷基甲基,
1H-咪唑-4-基甲基,4-
噻唑基甲基或(2-
氨基-4-
噻唑基)甲基;B为肾素底物过渡态类似物,例如,[1(S)-(环己基甲基)-2(R),3(S)-二羟基-5-甲基己基]
氨基。这些化合物抑制肾素活性,适用于治疗高血压和充血性心力衰竭。